NeoStrata

NeoStrata is a United States dermatological skincare brand based in Princeton, New Jersey. It was formed in 1988 by dermatologist Dr. Eugene J. Van Scott and dermatopharmacologist Dr. Ruey J. Yu, the two researchers credited with identifying the skin-renewing effects of Alpha Hydroxy Acids [7]. The brand builds its range around chemical exfoliation and skin turnover, and its professional peels and at-home products are sold across the United States, Canada and dozens of other markets, including the Nordic countries.

Since 2016 the company has been part of a larger corporate group: Johnson & Johnson Consumer Inc. acquired NeoStrata that year, and that consumer-health business was later spun off as the independent company Kenvue, which is NeoStrata's current owner [7][8]. The brand continues to operate and launch new products under that ownership.

NeoStrata traces its science to the 1970s. While treating patients with ichthyosis, an inherited condition that causes very dry, scaling skin, Van Scott and Yu found that Alpha Hydroxy Acids speed up the skin's natural process of shedding old cells and renewing its surface. According to the company, this insight reshaped how the wider skincare industry uses acids for visible results. International brand material dates the discovery to 1974, the year the two researchers co-authored what it describes as the first published scientific paper on the benefits of AHAs in dermatology [9].

The pair turned that research into a business roughly two decades later. The brand's name reflects its purpose, combining the Greek word for "new" (neo) with the Latin word for "layers" (strata) to signal products meant to renew the surface layers of the skin. Van Scott held the standing of Master of Dermatology in the American Academy of Dermatology, while Yu worked as a dermatopharmacologist [10].

The brand reports a gap between the original discovery and the founding of the company. Its public records place the AHA discovery and first paper in 1974, while the firm itself, The NeoStrata Company, was formed in 1988 to develop and market AHA-based skincare [7][9]. This is why the brand's own materials sometimes speak of "50+ years" of heritage, counting from the 1974 research rather than the 1988 incorporation. Among the company's early outputs was the original patented glycolic acid peel, glycolic acid being the smallest molecule in the AHA family and a natural constituent of sugar cane [9].

In 2016, Johnson & Johnson Consumer Inc. announced it would acquire NeoStrata Company, Inc., together with its affiliates and parent holding company, TriStrata, Incorporated [7]. The transaction, reported that April, also brought in the sister brand Exuviance; financial terms were not disclosed [8]. The trade press described NeoStrata at the time as a US dermocosmetics firm, and J&J framed the purchase as a way to add advanced skincare to its global consumer portfolio.

NeoStrata is owned by Kenvue Inc. The path to that ownership runs through Johnson & Johnson: J&J's consumer division acquired the brand in 2016, and in 2023 that division was separated from Johnson & Johnson to become Kenvue, an independent consumer-health company [8]. The current NeoStrata website confirms the link, routing its privacy notice to Kenvue's corporate domain. Under Kenvue, NeoStrata sits alongside skincare and personal-care names such as Aveeno, Clean & Clear, Piz Buin and Exuviance.

NeoStrata positions itself as a clinically driven, dermatologist-founded skincare brand, summed up in its tagline "We Are A Dermatologist Born Brand". Its stated belief is that visible results come from renewing the layers of the skin, and the company says it formulates products at bioavailable pH levels so that active ingredients are delivered effectively. Proof is a recurring theme in its messaging: the brand cites its patents and published research as the basis for its claims and frames clinical evidence as central to how it works.

The range is organised into collections aimed at concerns such as fine lines, brightness, hydration and blemishes, and it spans cleansers, toners, serums, moisturisers, sun protection and peels. NeoStrata describes its products as clinically proven to accelerate skin turnover, and states that results can be visible in as little as three days. Such efficacy statements are the company's own.

The brand's foundation is acid-based exfoliation, beginning with Alpha Hydroxy Acids such as glycolic acid. Over time its founders also patented the use of Polyhydroxy Acids (PHAs) such as gluconolactone and lactobionic acid, which the company presents as gentler exfoliants suitable for sensitive skin and less likely to increase sun sensitivity. Beyond exfoliating acids, NeoStrata developed several proprietary ingredients, including NeoGlucosamine, an amino sugar described as a non-acid exfoliant; Aminofil, an amino-acid derivative aimed at volume and firmness; and MicroDiPeptide229, which the brand calls its most powerful patented technology, targeting components of the skin's support structure such as collagen and elastin.

Signature products include the Tri-Therapy Lifting Serum, built around MicroDiPeptide229 and marketed as the brand's most powerful serum, and the professional NEOSTRATA ProSystem peels, which the company says are performed by skincare professionals in more than 50 countries. Third-party skincare writers have noted that NeoStrata's patented complex uses arginine to partially buffer glycolic acid, creating a gradual-release system intended to deliver sustained exfoliation with less irritation than an unbuffered formula of the same strength.

The company describes its products as backed by an extensive research record. It states that it holds more than 100 patents in the field of AHAs and PHAs [1], a figure echoed by an independent skin-health foundation, which has cited a medical heritage of well over 100 patents and close to 250 clinical studies and journal papers [10].

NeoStrata publishes a set of commitments focused on packaging and sourcing. The company says it aims to reduce packaging waste, increase recyclability, responsibly source its packaging and sustainably source palm oil [2]. It also lists ingredients it formulates without, among them oxybenzone, microbeads, phthalates, hydroquinone and sodium lauryl sulfate.

On animal testing, the company states that it does not conduct animal testing in the research or development of its cosmetic products, while acknowledging that some countries still require animal-testing data to approve new cosmetics for sale. On gluten, it says its products do not contain gluten but are made in shared facilities, so a gluten-free environment cannot be guaranteed. The brand does not cite third-party certifications such as Leaping Bunny or B Corp.

NeoStrata's founders have been recognised in the dermatology field for their AHA research rather than the brand for product awards. In 2008 the dermatology trade outlet MDedge published a piece on the honouring of Van Scott and Yu as Alpha Hydroxy Acid pioneers [11]. Press coverage of the brand itself has skewed toward skin-science and trade outlets, including reporting on the 2016 Johnson & Johnson acquisition; no dedicated mainstream-fashion brand history was identified in the available sources.

NeoStrata is active and owned by Kenvue. The brand operates a current e-commerce site, carries a 2026 copyright, has tagged recent product launches as new and maintains an educational blog on skincare topics. Its reach is global: professional peels are offered in more than 50 countries and its at-home products are sold in more than 70, including in the Nordic markets. Its status is best described as an operating sub-brand within the Kenvue group rather than an independent company.